Study. Abstract presented at XVIII International Workshop on CLL (iwCLL) Meeting. 2019 iwCLL
meeting abstracts.
10. Shanafelt TD, Wang XV, Kay NE, et al. Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic
Lymphocytic Leukemia. N Engl J Med. 2019; 381:432-443.
11. Woyach JA, Ruppert AS, Heerema NA, et al. Ibrutinib Regimens versus Chemoimmunotherapy
in Older Patients with Untreated CLL. N Engl J Med. 2018; 379:2517-2528
12. Shanafelt TD, Wang V, Kay NE, et al. Ibrutinib and Rituximab Provides Superior Clinical
Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL):
Extended Follow-up from the E1912 Trial. Blood. 2019;13;134 (Supplement 1):33.